0001209191-21-011551.txt : 20210217
0001209191-21-011551.hdr.sgml : 20210217
20210217200046
ACCESSION NUMBER: 0001209191-21-011551
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210214
FILED AS OF DATE: 20210217
DATE AS OF CHANGE: 20210217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NEUPERT PETER M
CENTRAL INDEX KEY: 0001237566
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38957
FILM NUMBER: 21647113
MAIL ADDRESS:
STREET 1: 13920 SE EASTGATE WAY
STREET 2: STE 300
CITY: BELLEVUE
STATE: WA
ZIP: 98005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp
CENTRAL INDEX KEY: 0001478320
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 270907024
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-659-0067
MAIL ADDRESS:
STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptive TCR Corp
DATE OF NAME CHANGE: 20091209
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-14
0
0001478320
Adaptive Biotechnologies Corp
ADPT
0001237566
NEUPERT PETER M
C/O ADAPTIVE BIOTECHNOLOGIES CORP.
SUITE 200
SEATTLE
WA
98102
1
0
0
0
Common Stock
2021-02-14
4
A
0
1504
0.00
A
1504
D
Stock Option (Right to Buy)
66.50
2021-02-14
4
A
0
3759
0.00
A
2031-02-14
Common Stock
3759
3759
D
The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date.
/s/ Peter Neupert by Eric Billings, attorney-in-fact
2021-02-17